Sriram Ravichandran
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
New Validated Staging System for Light Chain (AL) Amyloidosis With Stage IIIC Defining Ultra-Poor Risk: AL International Staging System.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 07, 2025
Evaluation of CD68+ macrophages in relation to kidney outcomes in immunoglobulin light-chain amyloidosis.
Journal: Kidney international
Published: November 08, 2025
Biochemical triple testing to exclude monoclonal gammopathy for non-biopsy diagnosis of transthyretin amyloid cardiomyopathy.
Journal: European journal of heart failure
Published: October 01, 2025
Revised renal stratification and progression models for predicting long-term renal outcomes in immunoglobulin light chain amyloidosis.
Journal: Haematologica
Published: February 27, 2025
Outcomes of daratumumab-bortezomib-thalidomide-dexamethasone in treatment-naive systemic AL amyloidosis.
Journal: British journal of haematology
Published: November 02, 2024
Ethnicity in systemic AL amyloidosis may impact risk stratification.
Journal: Haematologica
Published: October 03, 2024
Refining prognostication in systemic AL amyloidosis: limited value of dFLC.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: September 23, 2024
Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis.
Journal: JAMA cardiology
Published: August 21, 2024
Response rates to second-line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib-based regime.
Journal: British journal of haematology
Published: December 06, 2023
Healthcare Resource Utilization and Cost-of-Illness in Systemic Light Chain (AL) Amyloidosis in Europe: Results From the Real-World, Retrospective EMN23 Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: November 23, 2023
Limited utility of Mayo 2012 cardiac staging system for risk stratification of patients with advanced cardiac AL amyloidosis - analysis of a uniformly treated cohort of 1,275 patients.
Journal: Haematologica
Published: September 22, 2023
Last Updated: 09/26/2026